Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current revenue (TTM ) is NZ$18.40 Billion. In 2024 the company made a revenue of NZ$18.85 Billion a decrease over the revenue in the year 2023 that were of NZ$21.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.